Ongoing Phase 2 study enrolling 102 patients in the U.S. and South Korea, with more than 50% of participants identified as Asian ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that its prostate cancer PET[1] ...

BioVaxys Technology Corp. (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to provide a summary of current operating initiatives including the integration and disposition of assets acquired in ...

The fact that the COVID-19 vaccine is not available for newborn babies is shielding a group of prisoners on Georgia's death ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

Get Ready is proud to launch the 'Become a Willing Bystander' Program in support of the Stevenson Memorial Hospital ...

Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug ...

A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.

At-home colon cancer tests aren't the right option for people with a history of colon cancer or high-risk conditions, such as ...

The gathering in Tampa drew women from as as far as Europe. It was organized by the Breast Implant Safety Alliance, a ...

In some cases, counterfeit drugs have landed people in the hospital, including three people in the United States whose blood ...

The acquisition includes a rare immunology disease medicine, Ayvakit/Ayvakyt (avapritinib), approved in the US and the EU, and a promising advanced and early-stage immunology pipeline. Furthermore, ...